Mutual Funds Against Cancer (MFAC) is one of the leading advocates in the fight against cancer within the mutual fund and financial services industries. All proceeds benefit the Center for Applied Cancer Science (CACS), part of the Belfer Institute for Innovative Cancer Science at Dana-Farber Cancer Institute. This innovative institute is focused on accelerating the translation of scientific discoveries into new drugs aimed at combating the six dealiest forms of cancer: colon, pancreatic, lung, melanoma (skin), myeloma (blood), and glioblastoma (brain).